Boston Scientific to buy Penumbra for $14.5B, expanding neurovascular thrombectomy, with long-term margin gains. Click here ...

Boston Scientific has agreed to acquire Penumbra in a cash-and-stock deal worth $14.5 billion. The addition of Penumbra, ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

Boston Scientific is capping off a busy week with a major buyout, entering a deal worth around $14.5 billion to acquire ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

A case report describes mechanical thrombectomy performed 28 hours after stroke onset, guided by CT perfusion showing salvageable tissue, with marked neurologic recovery at discharge.

West Tennessee Healthcare has earned The Joint Commission’s Gold Seal of Approval and Thrombectomy-Capable Stroke ...